The only free news source for serious moves across finance

Archive

Browse all published articles from our finance deal feed

CAP

Public Credit Market Is Past Peak Defaults, BlackRock’s Lynam Says

Amanda Lynam, head of macro credit research at BlackRock, sees a scenario for liquid and private corporate credit markets of “dispersion, but not wide-spread market disruption.

Amanda Lynam, head of macro credit research at BlackRock, sees a scenario for liquid and private corporate credit markets of “dispersion, but not wide-spread market disruption.” (Source: Bloomberg)
Bloomberg MarketsDec 1, 1:55 PM
MA

BlockchAIn Digital Infrastructure to Acquire Signing Day Sports and One Blockchain in Strategic Merger

BlockchAIn Digital Infrastructure, Inc. is set to acquire Signing Day Sports, Inc. and One Blockchain LLC through a comprehensive Business Combination Agreement valued at approximately $207.5 million. This merger aims to enhance BlockchAIn's market position and operational capabilities in the digital infrastructure sector.

In a significant move within the digital infrastructure sector, BlockchAIn Digital Infrastructure, Inc. has entered into a Business Combination Agreement with Signing Day Sports, Inc. and One Blockchain LLC. This merger, announced on May 27, 2025, and amended on November 10, 2025, will see Signing Day Sports and One Blockchain merge into wholly-owned subsidiaries of BlockchAIn, creating a combined entity poised for growth. The deal involves two key transactions: the merger of BCDI Merger Sub...
USFMDec 1, 1:36 PM
REG

UK to Agree Drug Pricing Deal With US, Cut Rebates Paid to NHS

The UK is set to announce a pharmaceutical deal with President Donald Trump that includes tariff-free imports to the US, as well as a significant reduction in rebates paid by drugmakers to the National Health Service.

The UK is set to announce a pharmaceutical deal with President Donald Trump that includes tariff-free imports to the US, as well as a significant reduction in rebates paid by drugmakers to the National Health Service.
Bloomberg PoliticsDec 1, 1:05 PM
REG

UK to Agree Drug Pricing Deal With US, Cut Rebates to NHS

The UK is set to announce a pharmaceutical deal with President Donald Trump that includes tariff-free imports to the US, as well as a significant reduction in rebates paid by drugmakers to the National Health Service.

The UK is set to announce a pharmaceutical deal with President Donald Trump that includes tariff-free imports to the US, as well as a significant reduction in rebates paid by drugmakers to the National Health Service.
Bloomberg PoliticsDec 1, 1:05 PM
REG

US, UK Announce Deal on Pharmaceutical Tariffs, Drug Pricing

The Trump administration has reached an agreement with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to Britain’s National Health Service.

The Trump administration has reached an agreement with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to Britain’s National Health Service.
Bloomberg PoliticsDec 1, 1:05 PM
REG

US, UK Agree Deal on Pharmaceutical Tariffs, Drug Pricing

The Trump administration reached a deal with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to Britain’s National Health Service.

The Trump administration reached a deal with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to Britain’s National Health Service.
Bloomberg PoliticsDec 1, 1:05 PM
REG

Meloni Faces Opposition Criticism for ‘Rigging’ Paschi Deal

Italian Prime Minister Giorgia Meloni is facing criticism from opposition lawmakers over the government’s role in an alleged market-manipulation scheme related to Banca Monte dei Paschi di Siena SpA’s €17 billion ($19.

Italian Prime Minister Giorgia Meloni is facing criticism from opposition lawmakers over the government’s role in an alleged market-manipulation scheme related to Banca Monte dei Paschi di Siena SpA’s €17 billion ($19.8 billion) takeover of Mediobanca SpA.
Bloomberg PoliticsDec 1, 12:56 PM